Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Elanco Animal Health Incorporated is a global animal health company that develops, manufactures, and markets products and services to prevent and treat disease in farm animals and pets. With a strong focus on innovation, Elanco offers a comprehensive portfolio of solutions that improve animal well-being, support veterinarians and farmers, and contribute to a safe, affordable, and sustainable food supply. The company is committed to enriching life by advancing the health of animals, people, and the planet.
Serves as the central hub for global operations, research and development leadership, strategic planning, and corporate functions, driving Elanco's mission to advance animal health worldwide.
A modern, environmentally conscious 45-acre campus featuring flexible workspaces, advanced research labs, collaborative hubs, and green spaces, part of a larger 90-acre site dedicated to animal health innovation.
Emphasizes innovation, collaboration, and a purpose-driven environment focused on animal well-being. The headquarters is designed to attract top talent and foster a dynamic, agile, and inclusive culture.
Represents a major investment in Elanco's future, consolidating its R&D and corporate capabilities to accelerate innovation and growth. It also signifies a commitment to the Indiana life sciences community and sustainable practices.
Elanco supports a wide range of global functions including research and development, manufacturing and supply chain management, sales and marketing, regulatory affairs, and customer support. With a commercial presence in more than 90 countries, Elanco ensures its animal health solutions reach veterinarians, farmers, and pet owners worldwide, tailored to local needs and regulations.
2500 Innovation Way
Greenfield
Indiana
USA
Address: Mattenstrasse 24a, 4058 Basel, Switzerland
To drive growth and market penetration in the EMEA region, addressing specific animal health needs and regulatory landscapes of European and surrounding countries for both companion animals and livestock.
Address: 24 Rue de l'Industrie, 68330 Huningue, France
Supports Elanco's global R&D and manufacturing network, focusing on the development and production of key animal health treatments and preventatives, leveraging its strategic location in the BioValley.
Address: Unit 01-05, 29F, Tower A, NEO, No. 333 Tianyaoqiao Road, Xuhui District, Shanghai, China
To expand Elanco's presence and cater to the growing demand for animal health solutions for both livestock and companion animals in China and surrounding regions.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Elanco' leadership includes:
Elanco has been backed by several prominent investors over the years, including:
Elanco has made strategic executive appointments and seen some transitions over the past 12 months, focusing on strengthening its U.S. Pet Health division, corporate strategy, and international operations. Key hires have been made to lead these areas, alongside planned retirements and role adjustments within the senior leadership team.
Discover the tools Elanco uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Elanco primarily utilizes the [first_name].[last_name]@elanco.com email format for its employees. Another common format observed is [last_name]_[first_initial]@elanco.com.
[first_name].[last_name]@elanco.com OR [last_name]_[first_initial]@elanco.com
Format
jane.doe@elanco.com or doe_j@elanco.com
Example
85%
Success rate
Elanco Investor Relations • May 7, 2024
Elanco announced its financial results for the first quarter of 2024, reporting revenue of $1.206 billion, a 4% increase. The company highlighted growth in Pet Health driven by innovation and U.S. Farm Animal returning to growth, alongside strong performance from recent product launches and progress on productivity initiatives....more
Elanco.com Newsroom • April 2, 2024
Elanco Animal Health Incorporated announced that Zenrelia™, its targeted, non-cytotoxic therapy for canine dermatology, has received marketing authorization from the European Commission. Zenrelia™ is indicated for the treatment of clinical manifestations associated with atopic dermatitis in dogs....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Elanco, are just a search away.